Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MxBiodevices
AddedFeb 18, 2024
UpdatedJun 18, 2026
MxBiodevices

MxBiodevices

Closed

MxBiodevices, a nano scaffold provider, specializes in E-Matrix treatments for chronic wounds and ulcers.

HQ
Greenville, NC, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

Founded in August 2009, MxBiodevices focuses on commercializing an injectable nano scaffold, E-Matrix, designed for the treatment of diabetic foot ulcers (DFUs) and other chronic wounds. The company's core mission is to revolutionize wound care through advanced nanotechnology, improving patient outcomes and reducing healthcare costs. MxBiodevices offers a range of E-Matrix products that have found success in orthopedics and spine treatments, and they hold an exclusive license for E-Matrix applications in chronic wound care.

The founders of MxBiodevices have been pivotal in the development of E-Matrix over the past decade, leading to six commercially successful products. Key achievements include securing the exclusive license for E-Matrix in chronic wound treatment in February 2012. The company's innovative approach has significantly impacted the medical field, providing effective solutions for difficult-to-treat conditions like DFUs and decubitus ulcers.

MxBiodevices - Similar Companies

Imbed Biosciences logo

Imbed Biosciences

imbedbio.com

Biofisica logo

Biofisica

biofisica.com

Medtric logo

Medtric

medtricbiotech.com

Molecular Matrix logo

Molecular Matrix

NeXtGen Biologics logo

NeXtGen Biologics

MHB Labs logo

MHB Labs

MLM Biologics logo

MLM Biologics

mlmbiologics.com

BiomedInnovations logo

BiomedInnovations

Endomimetics logo

Endomimetics

endomimetics.com

MX Orthopedics logo

MX Orthopedics

Noxsano logo

Noxsano

noxsano.com

BioNanovations logo

BioNanovations

Reprise Biomedical logo

Reprise Biomedical

reprisebio.com

MatrixMed logo

MatrixMed

matrixmed.co

EmboMedics logo

EmboMedics

MxBiodevices - Quick Facts

Who are MxBiodevices' competitors?

Companies similar to MxBiodevices include Imbed Biosciences, Biofisica, Medtric and Molecular Matrix.

When was MxBiodevices founded?

MxBiodevices was founded in 2009.

Where is MxBiodevices' headquarters located?

MxBiodevices' headquarters is located in Greenville, NC, US.

When was MxBiodevices' last funding round?

MxBiodevices' most recent funding round was for $210k (USD) in February 2014.

How much has MxBiodevices raised to-date?

As of Feb 10, 2014, MxBiodevices has raised a total of $210k (USD).

MxBiodevices - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Nanotechnology
Geographic Exposure
  • Americas
Revenue
  • Transactional
Main Product
  • Medical Devices
Tags
  • Biotech
  • Healthtech
  • Medical
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified